• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
What Predicts a Clinical Discussion About PrEP? Results From Analysis of a U.S. National Cohort of HIV-Vulnerable Sexual and Gender Minorities.什么因素预示着会进行关于 PrEP 的临床讨论?来自美国易感染 HIV 的性少数群体和性别少数群体的全国队列分析的结果。
AIDS Educ Prev. 2022 Jun;34(3):195-208. doi: 10.1521/aeap.2022.34.3.195.
2
Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.在实践环境中获得艾滋病毒暴露前预防:性少数群体和性别少数群体成年人观点的定性研究。
J Gen Intern Med. 2019 Apr;34(4):535-543. doi: 10.1007/s11606-019-04850-w. Epub 2019 Feb 4.
3
Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.2021-2022 年美国南部性少数群体和性别少数群体对长效注射型 PrEP 的使用意愿和偏好:横断面研究。
J Int AIDS Soc. 2023 Mar;26(3):e26077. doi: 10.1002/jia2.26077.
4
Parental Concerns of Their Sexual and Gender Minority Adolescents Using HIV Pre-Exposure Prophylaxis.家长对其使用艾滋病毒暴露前预防的性少数和性别少数青少年的担忧。
AIDS Educ Prev. 2023 Feb;35(1):85-99. doi: 10.1521/aeap.2023.35.1.85.
5
Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.为男同性恋者和双性恋者提供的基于家庭的暴露前预防(PrEP)服务:解决PrEP使用和持续存在障碍的一个契机。
PLoS One. 2017 Dec 27;12(12):e0189794. doi: 10.1371/journal.pone.0189794. eCollection 2017.
6
Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.韩国医务人员和男男性行为者对 HIV 暴露前预防的认识和接受程度。
J Korean Med Sci. 2018 Mar 19;33(12):e91. doi: 10.3346/jkms.2018.33.e91.
7
PrEP Uptake and Methamphetamine Use Patterns in a 4-Year U.S. National Prospective Cohort Study of Sexual and Gender Minority People, 2017-2022.2017-2022 年美国性少数群体和跨性别者前瞻性队列研究:预防用药的使用和甲基苯丙胺使用模式。
AIDS Behav. 2024 Jun;28(6):2078-2086. doi: 10.1007/s10461-024-04306-1. Epub 2024 Mar 4.
8
An Exploratory Study of the PrEP Modality Preferences Among a Convenience Sample of Parents of Sexual and Gender Minority Adolescents.对性少数和性别少数青少年家长便利样本中暴露前预防方式偏好的探索性研究。
J Adolesc Health. 2023 Oct;73(4):625-631. doi: 10.1016/j.jadohealth.2023.02.015. Epub 2023 Apr 6.
9
Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.打破惯性:在美国纵向全国性少数群体 HIV 高危人群队列研究中沿着 HIV 预防治疗连续体推进。
J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):e118-e125. doi: 10.1097/QAI.0000000000002611.
10
Qualitative investigation of factors impacting pre-exposure prophylaxis initiation and adherence in sexual minority men.定性研究影响男同性恋者暴露前预防用药起始和坚持的因素
Health Expect. 2022 Feb;25(1):313-321. doi: 10.1111/hex.13382. Epub 2021 Dec 14.

引用本文的文献

1
Understanding Intentions to Discuss Long-Acting Injectable Pre-Exposure Prophylaxis with Healthcare Providers Among Black and Hispanic Gay and Bisexual Men in Texas.了解德克萨斯州黑人和西班牙裔男同性恋者及双性恋者与医疗服务提供者讨论长效注射暴露前预防措施的意愿。
J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251336662. doi: 10.1177/23259582251336662. Epub 2025 Apr 30.
2
PrEP Use in a US National Sample of Trans Men and Other Transmasculine People Who Have Sex With Men: A Longitudinal Analysis.在美国男男性行为的跨性别男性和其他跨性别男性人群全国样本中使用暴露前预防(PrEP):一项纵向分析。
J Acquir Immune Defic Syndr. 2024 Dec 1;97(4):357-363. doi: 10.1097/QAI.0000000000003492.
3
Characterizing Event-Driven PrEP Use and Investigating its Association with Experiences of PrEP-Related Barriers Among a US National Sample of PrEP Users.在美国全国范围的暴露前预防(PrEP)使用者样本中,对事件驱动型PrEP使用情况进行特征描述,并调查其与PrEP相关障碍经历之间的关联。
AIDS Behav. 2025 Feb;29(2):642-651. doi: 10.1007/s10461-024-04546-1. Epub 2024 Nov 12.

本文引用的文献

1
Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.打破惯性:在美国纵向全国性少数群体 HIV 高危人群队列研究中沿着 HIV 预防治疗连续体推进。
J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):e118-e125. doi: 10.1097/QAI.0000000000002611.
2
The Pre-Exposure Prophylaxis Cascade in At-Risk Transgender Men Who Have Sex with Men in the United States.美国有男男性行为风险的跨性别男性中的暴露前预防(PrEP)级联反应。
LGBT Health. 2021 Feb-Mar;8(2):116-124. doi: 10.1089/lgbt.2020.0232. Epub 2021 Feb 9.
3
Communication Strategies for Discussing PrEP with Men Who Have Sex with Men.与男男性行为者讨论 PrEP 的沟通策略。
J Homosex. 2022 Jan 2;69(1):61-74. doi: 10.1080/00918369.2020.1813509. Epub 2020 Aug 25.
4
Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.医护人员与患者在 HIV 预防的暴露前预防(PrEP)方面的沟通:对医护人员挑战的探索。
Health Commun. 2021 Nov;36(13):1677-1686. doi: 10.1080/10410236.2020.1787927. Epub 2020 Jul 7.
5
Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare.利用电子健康记录识别人类免疫缺陷病毒暴露前预防的候选者:当结局罕见时,超级学习在风险预测中的应用。
Stat Med. 2020 Oct 15;39(23):3059-3073. doi: 10.1002/sim.8591. Epub 2020 Jun 24.
6
Telehealth transformation: COVID-19 and the rise of virtual care.远程医疗转型:COVID-19 与虚拟医疗的兴起。
J Am Med Inform Assoc. 2020 Jun 1;27(6):957-962. doi: 10.1093/jamia/ocaa067.
7
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.美国广泛使用暴露前预防措施的障碍:叙事性综述。
Adv Ther. 2020 May;37(5):1778-1811. doi: 10.1007/s12325-020-01295-0. Epub 2020 Mar 30.
8
An overview of clinical decision support systems: benefits, risks, and strategies for success.临床决策支持系统概述:益处、风险及成功策略。
NPJ Digit Med. 2020 Feb 6;3:17. doi: 10.1038/s41746-020-0221-y. eCollection 2020.
9
The HIV Pre-exposure Prophylaxis (PrEP) Cascade at NYC Sexual Health Clinics: Navigation Is the Key to Uptake.纽约市性健康诊所的 HIV 暴露前预防 (PrEP) 级联:导航是获得性的关键。
J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):357-364. doi: 10.1097/QAI.0000000000002274.
10
PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention.暴露前预防1.0及以后:优化生物行为干预措施
J Acquir Immune Defic Syndr. 2019 Dec 1;82 Suppl 2(2):S113-S117. doi: 10.1097/QAI.0000000000002169.

什么因素预示着会进行关于 PrEP 的临床讨论?来自美国易感染 HIV 的性少数群体和性别少数群体的全国队列分析的结果。

What Predicts a Clinical Discussion About PrEP? Results From Analysis of a U.S. National Cohort of HIV-Vulnerable Sexual and Gender Minorities.

机构信息

Department of Community Health and Social Sciences, City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York, New York.

CUNY School of Medicine.

出版信息

AIDS Educ Prev. 2022 Jun;34(3):195-208. doi: 10.1521/aeap.2022.34.3.195.

DOI:10.1521/aeap.2022.34.3.195
PMID:35647867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9212698/
Abstract

HIV-outcome inequities remain prevalent in the U.S. Medical providers (MPs) are gatekeepers of PrEP, and understanding the dynamics of PrEP assessments is of major interest for public health. We analyzed data from Together 5000, an internet-based U.S. national cohort of sexual and gender minority (SGM) individuals aged 16-49 years and at risk for HIV. Among those eligible for PrEP uptake (n = 6264), we modeled predictors of discussing PrEP with an MP. A third (31%) of participants had spoken to a MP about PrEP. Among those who spoke to a MP, 45% suggested they would initiate PrEP; this outcome was more common among participants older than 24. With a persistent stagnant uptake nationwide, new opportunities to influence PrEP uptake must be explored. An attractive less targeted space is the medical office, specifically ways to support an initial and continued discussion about PrEP between MPs and their patients.

摘要

艾滋病毒相关结局的不平等在美国仍然普遍存在。医疗保健提供者(MPs)是 PrEP 的把关人,了解 PrEP 评估的动态对于公共卫生具有重要意义。我们分析了来自 Together 5000 的数据,这是一个基于互联网的美国性少数群体(SGM)年龄在 16-49 岁且有感染艾滋病毒风险的人群的全国性队列。在符合 PrEP 服用条件的人群中(n=6264),我们对与 MPs 讨论 PrEP 的预测因素进行了建模。三分之一(31%)的参与者曾与 MPs 讨论过 PrEP。在与 MPs 交谈过的人中,有 45%的人表示他们将开始服用 PrEP;这一结果在年龄超过 24 岁的参与者中更为常见。在全国范围内 PrEP 的使用率持续停滞不前的情况下,必须探索新的机会来影响 PrEP 的使用。一个有吸引力的、非目标性更强的空间是医疗办公室,特别是支持 MPs 与其患者之间就 PrEP 进行初始和持续讨论的方式。